“Taking lots of drugs is part of a healthy balanced lifestyle. They are all safe as long as my sponsors are making them.” This, in essence, is the message that we might expect from the top pharmaceutical industry lobbyist poised to run the FDA, America’s food and drug industry regulator.
As reported by By Carey Wedler for AntiMedia
President Obama’s recent nominee to chair the Food and Drug Administration has drawn harsh criticism for his ties to the pharmaceutical industry. The disapproval grew more justified this week as it was revealed that until this year, nominee Dr. Robert Califf was a board member and consultant for a company whose sole purpose is to help pharmaceutical companies evade and manipulate FDA regulations. He currently serves as the FDA’s deputy commissioner for medical products and tobacco and awaits Senate confirmation to become Deputy Commissioner of the agency.
Faculty Connection, LLC, where Califf served from 2006 to 2015, claims the company “brings together physicians and researchers from leading academic institutions with pharmaceutical, biotechnology and medical device clients.”
Further, an official corporate video notes the company has “served over 175 different pharma, biotech medical device firms,” claiming to help faculty — researchers, doctors, and academics — work side-by-side with the pharmaceutical industry. Continue reading...
– – – – – – –
I look at this subject in the chapter titled “The Drugs Problem” in my book, The State Is Out Of Date, We Can Do It Better – paragraphs from that below:
Society does have a problem with drug use. It is a serious problem that is getting worse. For some reason, though, the perception of this problem is focused entirely on the very small range of drugs that are being used illegally. We cannot ignore the very real problems faced by those who are using drugs prescribed by doctors. Their lives can be damaged and sometimes destroyed as a result of diagnostic error, their own abuse of the prescribed stocks (few recreational drug users have a month’s supply in a bottle), or just years of being dependent on pharmaceuticals with known side effects. These legal drugs must be obtained through controlled channels, but these channels translate into a multi-billion dollar industry throughout the world—the real drugs trade. While we condemn it when drug barons bribe and seduce judges, police, and politicians, we think nothing of the lobbyists employed by the pharmaceutical industry in Washington DC, who number more than three for every single Congressman or Senator. To rephrase that, there are 535 elected representatives shaping law and regulation in the capital of the United States, attended to by 1,724 paid persuaders from the pharmaceutical drug barons alone (as well as some 9,750 lobbyists from other interest groups in 2011).